Position in NVS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$840,332
+$205,503 QoQ
Shares Held
5,362
+29.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#682
of 1,603 holders
Holding Since
Mar 2020
19 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FDx Advisors, Inc. holds $3,475,495 across 7 Drug Manufacturers - General names. NVS ranks #1 (24.2% of the industry book) .
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $840,332 | 5,362 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $634,829 | 4,156 | Shares | Sole | 2026-05-01 | |
| 2024-03-31 | $454,050 | 4,694 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,652,777 | 16,369 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,601,035 | 15,718 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $2,993,394 | 29,664 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $5,316,404 | 57,787 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $5,242,436 | 57,787 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,463,535 | 58,723 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,460,722 | 64,601 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $5,512,191 | 62,817 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $5,158,105 | 58,970 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,876,699 | 47,404 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $4,007,534 | 43,923 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,623,839 | 42,394 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $4,459,456 | 47,225 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,705,887 | 42,616 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,659,371 | 41,898 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $3,215,797 | 39,003 | Shares | Sole | 2020-05-22 | |
| No filing history on record for this holder in this stock. | ||||||